ARTICLE | Company News
Vical, Merck deal
August 25, 2003 7:00 AM UTC
The companies amended a 1997 deal under which VICL granted MRK a worldwide development and marketing license to its naked DNA delivery technology for therapeutic vaccines against HIV and hepatitis B v...